Table 1:

DTI parameters in healthy controls, the total cohort of patients with myelitis, and different subgroups

	Healthy Controls	All Patients with or without Active Lesions	Patients without Active Lesions			Patients with Active Lesions
	Healthy Controls	All Patients with or without Active Lesions	Patients with MS and Other Patients^{^a}	Patients with MS	Other Patients^{^a}	Patients with Active Lesions
No.	12	40	34	20	14	6
Sex (F/M)	7:5	19:21	18:16	9:11	9:5	1:5
Age (yr) (mean)	31.6 ± 9.1	43.3 ± 12.0	43.6 ± 11.8	40.5 ± 13.0	48.0 ± 7.5	41.5 ± 14.7
FA (mean)	0.61 ± 0.01	0.54 ± 0.06	0.52 ± 0.05	0.54 ± 0.04	0.50 ± 0.05	0.64 ± 0.05
MD (10⁻³ mm²/s) (mean)	1.17 ± 0.07	1.30 ± 0.28	1.38 ± 0.22	1.40 ± 0.20	1.34 ± 0.25	0.84 ± 0.13
E1 = aD (10⁻³ mm²/s) (mean)	1.96 ± 0.10	2.02 ± 0.36	2.12 ± 0.28	2.17 ± 0.25	2.04 ± 0.32	1.45 ± 0.17
E2 (10⁻³ mm²/s) (mean)	0.92 ± 0.05	1.10 ± 0.27	1.18 ± 0.22	1.18 ± 0.20	1.18 ± 0.25	0.68 ± 0.12
E3 (10⁻³ mm²/s) (mean)	0.63 ± 0.06	0.77 ± 0.24	0.83 ± 0.19	0.84 ± 0.17	0.82 ± 0.23	0.39 ± 0.13
rD (10⁻³ mm²/s) (mean)	0.77 ± 0.05	0.93 ± 0.26	1.00 ± 0.20	1.00 ± 0.19	1.00 ± 0.23	0.53 ± 0.12
Ratio^{^b} (mean)	2.5 ± 0.08	2.25 ± 0.37	2.15 ± 0.25	2.20 ± 0.26	2.09 ± 0.22	2.82 ± 0.45

↵a Patients with myelitis with other causes of inflammatory myelopathy (neuromyelitis optica, sarcoidosis, Gougerot-Sjögren syndrome, idiopathic).
↵b Ratios of aD and rD.